Literature DB >> 2611972

Epidemiology and control of gonococcal ophthalmia neonatorum.

M Laga, A Meheus, P Piot.   

Abstract

From a public health point of view gonococcal ophthalmia neonatorum (GCON) is important as it can rapidly lead to blindness. The frequency of GCON is determined by the prevalence of maternal gonococcal infection. In most industrialized countries the prevalence of gonorrhoea in pregnant women is less than 1%; in developing countries the rates are between 3% and 15%, more than 50% being due to penicillinase-producing Neisseria gonorrhoeae strains (PPNG). The rate of transmission from mother to newborn is between 30% and 50%. Strategies for the control of GCON include: (1) prevention of gonococcal infection in women of childbearing age, (2) detection and treatment of gonococcal infection in pregnant women, (3) eye prophylaxis in the newborn at birth, and (4) diagnosis and treatment of GCON. Eye prophylaxis by the instillation immediately after birth of either 1% silver nitrate eye drops or 1% tetracycline eye ointment is very effective. This reduces the GCON incidence by 80% to 95% and is highly cost-effective, particularly in high-risk settings.

Entities:  

Keywords:  Age Factors; Biology; Demographic Factors; Diseases; Epidemiology; Family And Household; Family Characteristics; Family Relationships; Gonorrhea--prevention and control; Health; Infant; Infections; Literature Review; Mothers; Ophthalmological Effects--prevention and control; Parents; Physiology; Population; Population Characteristics; Public Health; Reproductive Tract Infections; Sexually Transmitted Diseases; Vertical Transmission; Youth

Mesh:

Substances:

Year:  1989        PMID: 2611972      PMCID: PMC2491298     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  15 in total

1.  Ophthalmia neonatorum in Nairobi, Kenya: the roles of Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  L Fransen; H Nsanze; V Klauss; P Van der Stuyft; L D'Costa; R C Brunham; P Piot
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

2.  In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda.

Authors:  J Bogaerts; J Vandepitte; E Van Dyck; R Vanhoof; M Dekegel; P Piot
Journal:  Genitourin Med       Date:  1986-08

3.  Is there a critical time for prophylaxis against neonatal gonococcal ophthalmia?

Authors:  L Muhe; N Tafari
Journal:  Genitourin Med       Date:  1986-10

4.  Sexually transmitted diseases among randomly selected attenders at an antenatal clinic in The Gambia.

Authors:  D C Mabey; N E Lloyd-Evans; S Conteh; T Forsey
Journal:  Br J Vener Dis       Date:  1984-10

5.  Ocular gonococcal infection with minimal or no inflammatory response.

Authors:  J K Podgore; K K Holmes
Journal:  JAMA       Date:  1981-07-17       Impact factor: 56.272

6.  Effects of silver nitrate on initial visual behavior.

Authors:  P M Butterfield; R N Ende; B B Platt
Journal:  Am J Dis Child       Date:  1978-04

7.  Gonococcal ophthalmia neonatorum. Relationship of time of infection to relevant control measures.

Authors:  T R Thompson; R E Swanson; P J Wiesner
Journal:  JAMA       Date:  1974-04-08       Impact factor: 56.272

8.  Screening for gonorrhea in a prenatal clinic in Southeast Asia.

Authors:  T H Goh; Y F Ngeow; S K Teoh
Journal:  Sex Transm Dis       Date:  1981 Apr-Jun       Impact factor: 2.830

9.  Antenatal screening for candidiasis, trichomoniasis, and gonorrhoea.

Authors:  R A Sparks; G L Williams; J M Boyce; T C Fitzgerald; G Shelley
Journal:  Br J Vener Dis       Date:  1975-04

10.  Gonorrhea in pregnancy.

Authors:  L E Edwards; M I Barrada; A A Hamann; E Y Hakanson
Journal:  Am J Obstet Gynecol       Date:  1978-11-15       Impact factor: 8.661

View more
  19 in total

Review 1.  Periodic health examination, 1992 update: 4. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

Review 2.  Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.

Authors:  S Mullick; D Watson-Jones; M Beksinska; D Mabey
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women.

Authors:  P Christian; S K Khatry; S C LeClerq; A A Roess; L Wu; J D Yuenger; J M Zenilman
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

5.  Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010-2015.

Authors:  Kristen Kreisel; Emily Weston; Jim Braxton; Eloisa Llata; Elizabeth Torrone
Journal:  Sex Transm Dis       Date:  2017-06       Impact factor: 2.830

6.  Preventing ophthalmia neonatorum.

Authors:  Dorothy L Moore; Noni E MacDonald
Journal:  Paediatr Child Health       Date:  2015-03       Impact factor: 2.253

Review 7.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

8.  Preventing ophthalmia neonatorum.

Authors:  Dorothy L Moore; Noni E MacDonald
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

9.  Visual impairment and blindness in Europe and their prevention.

Authors:  I Kocur; S Resnikoff
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

10.  Utility of Routine Testing for Chlamydia and Gonorrhea in the Setting of Preterm Delivery or Premature Preterm Rupture of Membranes.

Authors:  Kaitlynn Ebisutani; Charlie K Wang; Hyeong Jun Ahn; Autumn J Broady; Bliss Kaneshiro
Journal:  Hawaii J Health Soc Welf       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.